Multivariate analysis for prognostic significance of histologic subtype, GST-pi, MDR-1, and p53 in stages II-IV ovarian cancer
Authors:
- 1 November 2003
- journal article
- Published by Elsevier in International Journal of Gynecological Cancer
- Vol. 13 (6) , 776-784
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- p53 Mutation Is Infrequent in Clear Cell Carcinoma of the OvaryGynecologic Oncology, 2001
- Prognostic Significance of Lymph Node Metastasis and Clear Cell Histology in Ovarian Carcinoma Limited to the Pelvis (pT1M0 and pT2M0)Gynecologic Oncology, 2000
- Clinically Apparent Early Stage Invasive Epithelial Ovarian Carcinoma: Should All Be Treated Similarly?Gynecologic Oncology, 1999
- Multiple Drug Resistance Parameter Expression in Ovarian CancerGynecologic Oncology, 1998
- Expression of Genes of Potential Importance in the Response to Chemotherapy and DNA Repair in Patients with Ovarian CancerGynecologic Oncology, 1997
- Structure and Function of the p53 Tumor Suppressor Gene: Clues for Rational Cancer Therapeutic StrategiesJNCI: Journal of the National Cancer Institute, 1996
- MDR1 gene expression in solid tumoursEuropean Journal of Cancer, 1996
- Markers of Chemoresistance in Ovarian Carcinomas: An Immunohistochemical Study of 86 CasesInternational Journal of Gynecological Pathology, 1996
- The Prognostic Significance of Residual Disease, FIGO Substage, Tumor Histology, and Grade in Patients with FIGO Stage III Ovarian CancerGynecologic Oncology, 1995
- Clear Cell Epithelial Ovarian Cancer (Mesonephroid): Bad Prognosis Only in Early StagesGynecologic Oncology, 1993